Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

doi:10.1111/jvim.12181

Research article2013Peer reviewedOpen access

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

Abstract

Conclusions and Clinical ImportancePimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment. Pimobendan treatment resulted in smaller heart size, higher body temperature, and less retention of free water.

Keywords

Canine; Mitral regurgitation; Mortality; Therapy

Published in

Journal of Veterinary Internal Medicine
2013, volume: 27, number: 6, pages: 1441-1451
Publisher: WILEY-BLACKWELL

SLU Authors

Häggström, Jens
- Department of Clinical Sciences, Swedish University of Agricultural Sciences
Kvart, Clarence
- Department of Animal Biosciences, Swedish University of Agricultural Sciences

UKÄ Subject classification

Other Veterinary Science

Publication identifier

DOI: https://doi.org/10.1111/jvim.12181

Permanent link to this page (URI)

https://res.slu.se/id/publ/51698